EP2488640 - ANTIPROLIFERATIVE AGENT [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.08.2019 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 24.08.2018 | ||
Former | Grant of patent is intended Status updated on 10.04.2018 | ||
Former | Examination is in progress Status updated on 16.12.2016 | Most recent event Tooltip | 03.07.2020 | Lapse of the patent in a contracting state New state(s): CY, MK | published on 05.08.2020 [2020/32] | Applicant(s) | For all designated states Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | [2018/39] |
Former [2012/34] | For all designated states Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | Inventor(s) | 01 /
TAN, Nguan, Soon Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | 02 /
CHONG, Han, Chung Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | 03 /
TAN, Ming, Jie Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | 04 /
HUANG, Royston Nanyang Technological University 50 Nanyang Avenue Singapore 639798 / SG | [2012/34] | Representative(s) | Mader, Joachim, et al Bardehle Pagenberg Partnerschaft mbB Patentanwälte, Rechtsanwälte Prinzregentenplatz 7 81675 München / DE | [N/P] |
Former [2018/39] | Hess, Peter K. G. Bardehle Pagenberg Partnerschaft mbB Patentanwälte, Rechtsanwälte Prinzregentenplatz 7 81675 München / DE | ||
Former [2012/34] | Ratcliffe, Susan Margaret Acredian IP 27 Springhill Stroud Gloucestershire GL5 1TN / GB | Application number, filing date | 10823705.8 | 14.10.2010 | [2018/39] | WO2010SG00392 | Priority number, date | US20090251485P | 14.10.2009 Original published format: US 251485 P | [2012/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011046515 | Date: | 21.04.2011 | Language: | EN | [2011/16] | Type: | A1 Application with search report | No.: | EP2488640 | Date: | 22.08.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.04.2011 takes the place of the publication of the European patent application. | [2012/34] | Type: | B1 Patent specification | No.: | EP2488640 | Date: | 26.09.2018 | Language: | EN | [2018/39] | Search report(s) | International search report - published on: | AU | 21.04.2011 | (Supplementary) European search report - dispatched on: | EP | 04.12.2013 | Classification | IPC: | C12N15/00, C12N15/113, C07K16/00, A61P35/00, A61K31/7088, A61K39/395 | [2012/34] | CPC: |
A61P35/00 (EP);
C07K16/22 (EP,US);
C12N15/1136 (EP,US);
C12N15/1138 (EP,US);
A61K2039/505 (EP,US);
C12N2310/14 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/34] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | ANTIPROLIFERATIONSMITTEL | [2012/34] | English: | ANTIPROLIFERATIVE AGENT | [2012/34] | French: | AGENT ANTIPROLIFÉRATIF | [2012/34] | Entry into regional phase | 28.03.2012 | National basic fee paid | 28.03.2012 | Search fee paid | 28.03.2012 | Designation fee(s) paid | 28.03.2012 | Examination fee paid | Examination procedure | 12.08.2011 | Request for preliminary examination filed International Preliminary Examining Authority: AU | 28.03.2012 | Examination requested [2012/34] | 13.06.2014 | Amendment by applicant (claims and/or description) | 24.08.2016 | Despatch of a communication from the examining division (Time limit: M06) | 24.01.2017 | Reply to a communication from the examining division | 07.06.2017 | Despatch of a communication from the examining division (Time limit: M04) | 17.10.2017 | Reply to a communication from the examining division | 11.04.2018 | Communication of intention to grant the patent | 13.08.2018 | Fee for grant paid | 13.08.2018 | Fee for publishing/printing paid | 13.08.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.08.2016 | Opposition(s) | 27.06.2019 | No opposition filed within time limit [2019/36] | Fees paid | Renewal fee | 11.10.2012 | Renewal fee patent year 03 | 14.10.2013 | Renewal fee patent year 04 | 14.10.2014 | Renewal fee patent year 05 | 12.10.2015 | Renewal fee patent year 06 | 11.10.2016 | Renewal fee patent year 07 | 11.10.2017 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 14.10.2010 | AL | 26.09.2018 | AT | 26.09.2018 | CY | 26.09.2018 | CZ | 26.09.2018 | DK | 26.09.2018 | EE | 26.09.2018 | ES | 26.09.2018 | FI | 26.09.2018 | HR | 26.09.2018 | IT | 26.09.2018 | LT | 26.09.2018 | LV | 26.09.2018 | MC | 26.09.2018 | MK | 26.09.2018 | NL | 26.09.2018 | PL | 26.09.2018 | RO | 26.09.2018 | RS | 26.09.2018 | SE | 26.09.2018 | SI | 26.09.2018 | SK | 26.09.2018 | SM | 26.09.2018 | TR | 26.09.2018 | IE | 14.10.2018 | LU | 14.10.2018 | MT | 14.10.2018 | BE | 31.10.2018 | BG | 26.12.2018 | NO | 26.12.2018 | GR | 27.12.2018 | IS | 26.01.2019 | PT | 26.01.2019 | [2020/31] |
Former [2020/30] | HU | 14.10.2010 | |
AL | 26.09.2018 | ||
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
DK | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SI | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
TR | 26.09.2018 | ||
IE | 14.10.2018 | ||
LU | 14.10.2018 | ||
MT | 14.10.2018 | ||
BE | 31.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2020/17] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
DK | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SI | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
TR | 26.09.2018 | ||
IE | 14.10.2018 | ||
LU | 14.10.2018 | ||
MT | 14.10.2018 | ||
BE | 31.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2020/08] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
DK | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SI | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
IE | 14.10.2018 | ||
LU | 14.10.2018 | ||
MT | 14.10.2018 | ||
BE | 31.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/50] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
DK | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SI | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
IE | 14.10.2018 | ||
LU | 14.10.2018 | ||
BE | 31.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/48] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
DK | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
IE | 14.10.2018 | ||
LU | 14.10.2018 | ||
BE | 31.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/38] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
DK | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
LU | 14.10.2018 | ||
BE | 31.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/34] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
DK | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
LU | 14.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/33] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
MC | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
LU | 14.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/30] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
LU | 14.10.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/26] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SK | 26.09.2018 | ||
SM | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
PT | 26.01.2019 | ||
Former [2019/23] | AL | 26.09.2018 | |
AT | 26.09.2018 | ||
CZ | 26.09.2018 | ||
EE | 26.09.2018 | ||
ES | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
SK | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
Former [2019/22] | AL | 26.09.2018 | |
CZ | 26.09.2018 | ||
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
NL | 26.09.2018 | ||
PL | 26.09.2018 | ||
RO | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
Former [2019/21] | AL | 26.09.2018 | |
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
IT | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
NL | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
IS | 26.01.2019 | ||
Former [2019/20] | AL | 26.09.2018 | |
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
NL | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
Former [2019/12] | AL | 26.09.2018 | |
FI | 26.09.2018 | ||
HR | 26.09.2018 | ||
LT | 26.09.2018 | ||
LV | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
Former [2019/11] | FI | 26.09.2018 | |
HR | 26.09.2018 | ||
LT | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
Former [2019/10] | FI | 26.09.2018 | |
LT | 26.09.2018 | ||
RS | 26.09.2018 | ||
SE | 26.09.2018 | ||
BG | 26.12.2018 | ||
NO | 26.12.2018 | ||
GR | 27.12.2018 | ||
Former [2019/08] | FI | 26.09.2018 | |
LT | 26.09.2018 | ||
NO | 26.12.2018 | ||
Former [2019/07] | LT | 26.09.2018 | Documents cited: | Search | [XYI]WO2006014729 (GENENTECH INC [US], et al) [X] 1-3,5-8,10,11 * claim - * * paragraph [0194] * * the whole document * [Y] 4,9 [I] 12-14; | [Y]WO2006074228 (LEXICON GENETICS INC [US], et al) [Y] 4,9 * page 97 - page 98 * * page 102 - page 103 * | International search | [X]WO2006014678 (GENENTECH INC [US], et al); | [X]WO2006014729 (GENENTECH INC [US], et al); | [X]WO2006074228 (LEXICON GENETICS INC [US], et al); | [X]US2006019284 (HUANG FEI [US], et al); | [XP] - MA T ET AL., "Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma'", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20100726), pages 1 - 6, XP008154839 DOI: http://dx.doi.org/10.1073/pnas.1001065107 | Examination | WO2006044779 | - ZHANG Z ET AL, "Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells", CANCER LETTERS, NEW YORK, NY, US, vol. 267, no. 1, doi:10.1016/J.CANLET.2008.03.010, ISSN 0304-3835, (20080818), pages 106 - 115, (20080422), XP022797047 DOI: http://dx.doi.org/10.1016/j.canlet.2008.03.010 | by applicant | US4816567 | US5545807 | US5545806 | US5569825 | US5625126 | US5633425 | US5661016 | US4676980 | WO9100360 | WO9200373 | EP0003089 | US6667371 | US6613355 | US6596296 | US6413536 | US5968543 | US4079038 | US4093709 | US4131648 | US4138344 | US4180646 | US4304767 | US4946931 | - Immunology Methods Manual, Academic Press, (19970000), vol. 2 | - Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, (19880000), pages 78 - 87 | - Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, (19880000), pages 55 - 120 | - KOHLER; MILSTEIN, Nature, (19750000), vol. 256, page 495 | - KOZBOR, J., Immunol, (19840000), vol. 133, page 3001 | - JONES et al., Nature, (19860000), vol. 321, pages 522 - 525 | - RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327 | - VERHOEYEN et al., Science, (19880000), vol. 239, pages 1534 - 1536 | - HOOGENBOOM; WINTER, J., Mol. Biol., (19910000), vol. 227, page 381 | - MARKS et al., J. Mol. Biol., (19910000), vol. 222, page 581 | - COLE et al., Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, (19850000), page 77 | - BOEMER et al., J. Immunol., (19910000), vol. 147, no. 1, pages 86 - 95 | - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783 | - LONBERG et al., Nature, (19940000), vol. 368, pages 856 - 859 | - MORRISON, Nature, (19940000), vol. 368, pages 812 - 813 | - FISHWILD et al., Nature Biotechnology, (19960000), vol. 14, pages 845 - 851 | - NEUBERGER, Nature Biotechnology, (19960000), vol. 14, page 826 | - LONBERG; HUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93 | - MILSTEIN; CUELLO, Nature, (19830000), vol. 305, pages 537 - 539 | - MORDENTI; RESCIGNO, Pharmaceutical Research, (19920000), vol. 9, pages 17 - 25 | - MORENTI et al., Pharmaceutical Research, (19910000), vol. 8, pages 1351 - 1359 | - "The use of interspecies scaling in toxicokinetics", MORDENTI; CHAPPELL et al., Toxicokinetics and New Drug Development, Pergamon Press, (19890000), pages 42 - 96 | - CHONG, H.C.; TAN, M.J.; PHILIPPE, V.; TAN, S.H.; TAN, C.K.; KU, C.W.; GOH, Y.Y.; WAHLI, W.; MICHALIK, L.; TAN, N.S., "Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing", J Cell Biol, (20090000), vol. 184, pages 817 - 831 | - DESAI, U.; LEE, E.C.; CHUNG, K.; GAO, C.; GAY, J.; KEY, B.; HANSEN, G.; MACHAJEWSKI, D.; PLATT, K.A.; SANDS, A.T. et al., "Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice", Proc Natl Acad Sci U S A, (20070000), vol. 104, doi:doi:10.1073/pnas.0705041104, pages 11766 - 11771, XP008130955 DOI: http://dx.doi.org/10.1073/pnas.0705041104 | - DI POI, N.; TAN, N.S.; MICHALIK, L.; WAHLI, W.; DESVERGGNE, B., Mol. Cell, (20020000), vol. 10, pages 721 - 733 | - TANG, V.W., "Proteomic and bioinformatic analysis of epithelial tight junction reveals an unexpected cluster of synaptic molecules", Biology direct, (20060000), vol. 1, doi:doi:10.1186/1745-6150-1-37, page 37, XP021025702 DOI: http://dx.doi.org/10.1186/1745-6150-1-37 | - GIANNONI, E.; FIASCHI, T.; RAMPONI, G.; CHIARUGI, P., "Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals", Oncogene, (20090000), vol. 28, pages 2074 - 2086 | - AGGARWAL, B.B.; GEHLOT, P., "Inflammation and cancer: how friendly is the relationship for cancer patients?", Curr Opin Pharmacol, (20090000), vol. 9, doi:doi:10.1016/j.coph.2009.06.020, pages 351 - 369, XP026587067 DOI: http://dx.doi.org/10.1016/j.coph.2009.06.020 | - TAN, S.H.; PAL, M.; TAN, M.J.; WONG, M.H.L.; TAM, F.U.; TEO, J.W.T.; CHONG, H.C.; TAN, C.K.; GOH, Y.Y.; TANG, M.B.Y., "Regulation of Cell Proliferation and Migration by TAK1 via Transcriptional Control of von Hippel-Lindau Tumor Suppressor", J Biol Chem, vol. 284, pages 18047 - 18058 | - AKRAM, S.; TEONG, H.; FLIEGEL, L.; PERVAIZ, S.; CLEMENT, M., "Reactive oxygen species-mediated regulation of the Na+-H+ exchanger 1 gene expression connects intracellular redox status with cells' sensitivity to death triggers", Cell Death Differ, (20060000), vol. 13, pages 628 - 641 | - BELANGER, A.J.; LU, H.; DATE, T.; LIU, L.X.; VINCENT, K.A.; AKITA, G.Y.; CHENG, S.H.; GREGORY, R.J.; JIANG, C., "Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor lalpha", J Mol Cell Cardiol, (20020000), vol. 34, doi:doi:10.1006/jmcc.2002.2021, pages 765 - 774, XP008051648 DOI: http://dx.doi.org/10.1006/jmcc.2002.2021 | - BOUILLET, P.; STRASSER, A., "BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death", J Cell Sci, (20020000), vol. 115, pages 1567 - 1574, XP002972061 | - BRIDGE, A.J.; PEBERNARD, S.; DUCRAUX, A.; NICOULAZ, A.L.; IGGO, R., "Induction of an interferon response by RNAi vectors in mammalian cells", Nat Genet, (20030000), vol. 34, doi:doi:10.1038/ng1173, pages 263 - 264, XP002251051 DOI: http://dx.doi.org/10.1038/ng1173 | - CAZES, A.; GALAUP, A.; CHOMEL, C.; BIGNON, M.; BRECHOT, N.; LE JAN, S.; WEBER, H.; CORVOL, P.; MULLER, L.; GERMAIN, S. et al., "Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton", Circ Res, (20060000), vol. 99, pages 1207 - 1215 | - CHANCE, B.; SIES, H.; BOVERIS, A., "Hydroperoxide metabolism in mammalian organs", Physiol Rev, (19790000), vol. 59, pages 527 - 605 | - CHIARUGI, P., "From anchorage dependent proliferation to survival: lessons from redox signalling", IUBMB Life, (20080000), vol. 60, pages 301 - 307 | - CHIARUGI, P.; FIASCHI, T., "Redox signalling in anchorage-dependent cell growth", Cell Signal, (20070000), vol. 19, doi:doi:10.1016/j.cellsig.2006.11.009, pages 672 - 682, XP005897557 DOI: http://dx.doi.org/10.1016/j.cellsig.2006.11.009 | - CLEMENT, M.; PERVAIZ, S., "Intracellular superoxide and hydrogen peroxide concentrations: a critical balance that determines survival or death", Redox Rep, (20010000), vol. 6, pages 211 - 214 | - DESGROSELLIER, J.S.; CHERESH, D.A., "Integrins in cancer: biological implications and therapeutic opportunities", Nat Rev Cancer, (20100000), vol. 10, doi:doi:10.1038/nrc2748, pages 9 - 22, XP055016659 DOI: http://dx.doi.org/10.1038/nrc2748 | - EBLE, J.A.; HAIER, J., "Integrins in cancer treatment", Curr Cancer Drug Targets, (20060000), vol. 6, pages 89 - 105 | - FERRARO, D.; CORSO, S.; FASANO, E.; PANIERI, E.; SANTANGELO, R.; BORRELLO, S.; GIORDANO, S.; PANI, G.; GALEOTTI, T., "Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS", Oncogene, (20060000), vol. 25, pages 3689 - 3698 | - FIDLER, I.J., "Critical determinants of cancer metastasis: rationale for therapy", Cancer Chemother Pharmacol, (19990000), vol. 43, pages S3 - 10 | - GALAUP, A.; CAZES, A.; LE JAN, S.; PHILIPPE, J.; CONNAULT, E.; LE COZ, E.; MEKID, H.; MIR, L.M.; OPOLON, P.; CORVOL, P. et al., "Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness", Proc Natl Acad Sci U S A, (20060000), vol. 103, doi:doi:10.1073/pnas.0609025103, pages 18721 - 18726, XP002576800 DOI: http://dx.doi.org/10.1073/pnas.0609025103 | - GE, H.; YANG, G.; HUANG, L.; MOTOLA, D.L.; POURBAHRAMI, T.; LI, C., "Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4", J Biol Chem, (20040000), vol. 279, pages 2038 - 2045 | - GIANNONI, E.; BURICCHI, F.; GRIMALDI, G.; PARRI, M.; CIALDAI, F.; TADDEI, M.L.; RAUGEI, G.; RAMPONI, G.; CHIARUGI, P., "Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival", Cell Death Differ, (20080000), vol. 15, pages 867 - 878 | - HANAHAN, D.; WEINBERG, R.A., "The hallmarks of cancer", Cell, (20000000), vol. 100, pages 57 - 70, XP055447752 | - IRANI, K.; XIA, Y.; ZWEIER, J.L.; SOLLOTT, S.J.; DER, C.J.; FEARON, E.R.; SUNDARESAN, M.; FINKEL, T.; GOLDSCHMIDT-CLERMONT, P.J., "Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts", Science, (19970000), vol. 275, pages 1649 - 1652 | - ITO, Y.; OIKE, Y.; YASUNAGA, K.; HAMADA, K.; MIYATA, K.; MATSUMOTO, S.I.; SUGANO, S.; TANIHARA, H.; MASUHO, Y.; SUDA, T., "Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4", Cancer Res, (20030000), vol. 63, pages 6651 - 6657, XP002373803 | - JONESON, T.; BAR-SAGI, D., "A Racl effector site controlling mitogenesis through superoxide production", J Biol Chem, (19980000), vol. 273, pages 17991 - 17994 | - KERSTEN, S.; MANDARD, S.; TAN, N.S.; ESCHER, P.; METZGER, D.; CHAMBON, P.; GONZALEZ, F.J.; DESVERGNE, B.; WAHLI, W., "Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene", J Biol Chem, (20000000), vol. 275, doi:doi:10.1074/jbc.M004029200, pages 28488 - 28493, XP002217322 DOI: http://dx.doi.org/10.1074/jbc.M004029200 | - KOMATSU, D.; KATO, M.; NAKAYAMA, J.; MIYAGAWA, S.; KAMATA, T., "NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression", Oncogene, (20080000), vol. 27, pages 4724 - 4732 | - KOSTER, A.; CHAO, Y.; MOSIOR, M.; FORD, A.; GONZALEZ-DEWHITT, P.; HALE, J.; LI, D.; QIU, Y.; FRASER, C.; YANG, D., "Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl regulation of triglyceride metabolism", Endocrinology, (20050000), vol. 146, no. 3, doi:doi:10.1210/EN.2005-0476, pages 4943 - 4950, XP002416691 DOI: http://dx.doi.org/10.1210/EN.2005-0476 | - LE, J.; AMY, C.; CAZES, A.; MONNOT, C.; LAMANDE, N.; FAVIER, J.; PHILIPPE, J.; SIBONY, M.; GASC, J.; CORVOL, P. et al., "Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma", Am J Pathol, (20030000), vol. 162, pages 1521 - 1528, XP002377971 | - LEWIS, A.M.; VARGHESE, S.; XU, H.; ALEXANDER, H.R., "Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment", J Transl Med, (20060000), vol. 4, doi:doi:10.1186/1479-5876-4-48, page 48, XP055494595 DOI: http://dx.doi.org/10.1186/1479-5876-4-48 | - LI, C., "Genetics and regulation of angiopoietin-like proteins 3 and 4", Curr.Opin.Lipidol., (20060000), vol. 17, doi:doi:10.1097/01.mol.0000217896.67444.05, pages 152 - 156, XP009077842 DOI: http://dx.doi.org/10.1097/01.mol.0000217896.67444.05 | - LIOU, G.Y.; STORZ, P., "Reactive oxygen species in cancer", Free Radic Res, (20100000), vol. 44, doi:doi:10.3109/10715761003667554, pages 479 - 496, XP055289545 DOI: http://dx.doi.org/10.3109/10715761003667554 | - MACFARLANE, P.M.; SATRIOTOMO, I.; WINDELBORN, J.A.; MITCHELL, G.S., "NADPH oxidase activity is necessary for acute intermittent hypoxia-induced phrenic long-term facilitation", J Physiol, (20090000), vol. 587, pages 1931 - 1942 | - MINN, A.J.; GUPTA, G.P.; SIEGEL, P.M.; BOS, P.D.; SHU, W.; GIRI, D.D.; VIALE, A.; OLSHEN, A.B.; GERALD, W.L.; MASSAGUE, J., "Genes that mediate breast cancer metastasis to lung", Nature, (20050000), vol. 436, doi:doi:10.1038/nature03799, pages 518 - 524, XP002454668 DOI: http://dx.doi.org/10.1038/nature03799 | - MUELLER, M.M.; PETER, W.; MAPPES, M.; HUELSEN, A.; STEINBAUER, H.; BOUKAMP, P.; VACCARIELLO, M.; GARLICK, J.; FUSENIG, N.E., "Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor", Am J Pathol, (20010000), vol. 159, pages 1567 - 1579 | - MURPHY, G.J.; HOLDER, J.C., "PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer", Trends Pharmacol Sci, (20000000), vol. 21, doi:doi:10.1016/S0165-6147(00)01559-5, pages 469 - 474, XP004226378 DOI: http://dx.doi.org/10.1016/S0165-6147(00)01559-5 | - MUNZEL, T.; AFANAS'EV, I.B.; KLESCHYOV, A.L.; HARRISON, D.G., "Detection of superoxide in vascular tissue", Arterioscler Thromb Vasc Biol, (20020000), vol. 22, pages 1761 - 1768 | - OBERLEY, L.W., "Anticancer therapy by overexpression of superoxide dismutase", Antioxid Redox Signal, (20010000), vol. 3, pages 461 - 472 | - OIKE, Y.; AKAO, M.; KUBOTA, Y.; SUDA, T., "Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy", Trends Mol Med, (20050000), vol. 11, doi:doi:10.1016/j.molmed.2005.08.002, pages 473 - 479, XP005104728 DOI: http://dx.doi.org/10.1016/j.molmed.2005.08.002 | - PADUA, D.; ZHANG, X.H.F.; WANG, Q.; NADAL, C.; GERALD, W.L.; GOMIS, R.R.; MASSAGUE, J., "TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4", Cell, (20080000), vol. 133, doi:doi:10.1016/j.cell.2008.01.046, pages 66 - 77, XP055142791 DOI: http://dx.doi.org/10.1016/j.cell.2008.01.046 | - PAFFENHOLZ, R.; BERGSTROM, R.A.; PASUTTO, F.; WABNITZ, P.; MUNROE, R.J.; JAGLA, W.; HEINZMANN, U.; MARQUARDT, A.; BAREISS, A.; LAU, "Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase", Genes Dev, (20040000), vol. 18, doi:doi:10.1101/gad.1172504, pages 486 - 491, XP002293909 DOI: http://dx.doi.org/10.1101/gad.1172504 | - PANI, G.; GIANNONI, E.; GALEOTTI, T.; CHIARUGI, P., "Redox-based escape mechanism from death: the cancer lesson", Antioxid Redox Signal, (20090000), vol. 11, pages 2791 - 2806 | - PANIGRAHY, D.; HUANG, S.; KIERAN, M.W.; KAIPAINEN, A., "PPARgamma as a therapeutic target for tumor angiogenesis and metastasis", Cancer Biol Ther, (20050000), vol. 4, pages 687 - 693 | - PERVAIZ, S.; CLEMENT, M.V., "Superoxide anion: oncogenic reactive oxygen species?", Int J Biochem Cell Biol, (20070000), vol. 39, doi:doi:10.1016/j.biocel.2007.04.007, pages 1297 - 1304, XP022145769 DOI: http://dx.doi.org/10.1016/j.biocel.2007.04.007 | - PERVAIZ, S.; CLEMENT, M.V., "A permissive apoptotic environment: function of a decrease in intracellular superoxide anion and cytosolic acidification", Biochem Biophys Res Commun, (20020000), vol. 290, pages 1145 - 1150 | - PERVAIZ, S.; RAMALINGAM, J.K.; HIRPARA, J.L.; CLEMENT, M.V., "Superoxide anion inhibits drug-induced tumor cell death", FEBS Lett, (19990000), vol. 459, doi:doi:10.1016/S0014-5793(99)01258-2, pages 343 - 348, XP004375857 DOI: http://dx.doi.org/10.1016/S0014-5793(99)01258-2 | - PETERS, J.M.; GONZALEZ, F.J., "Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer", Biochim Biophys Acta, (20090000), vol. 1796, pages 230 - 241 | - SALMON, S.E., "Human tumor colony assay and chemosensitivity testing", Cancer Treat Rep, (19840000), vol. 68, pages 117 - 125 | - SHE, Q.B.; SOLIT, D.B.; YE, Q; O'REILLY, K.E.; LOBO, J.; ROSEN, N., "The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells", Cancer Cell, (20050000), vol. 8, doi:doi:10.1016/j.ccr.2005.09.006, pages 287 - 297, XP007920194 DOI: http://dx.doi.org/10.1016/j.ccr.2005.09.006 | - SHIBANUMA, M.; KUROKI, T.; NOSE, K., "Superoxide as a signal for increase in intracellular pH", J Cell Physiol, (19880000), vol. 136, pages 379 - 383 | - SINGH, S.; SADANANDAM, A.; SINGH, R.K., "Chemokines in tumor angiogenesis and metastasis", Cancer Metastasis Rev, (20070000), vol. 26, doi:doi:10.1007/s10555-007-9068-9, pages 453 - 467, XP019549270 DOI: http://dx.doi.org/10.1007/s10555-007-9068-9 | - SUH, Y.A.; ARNOLD, R.S.; LASSEGUE, B.; SHI, J.; XU, X.; SORESCU, D.; CHUNG, A.B.; GRIENDLING, K.K.; LAMBETH, J.D., "Cell transformation by the superoxide-generating oxidase Moxl", Nature, (19990000), vol. 401, doi:doi:10.1038/43459, pages 79 - 82, XP002233584 DOI: http://dx.doi.org/10.1038/43459 | - SUKONINA, V.; LOOKENE, A.; OLIVECRONA, T.; OLIVECRONA, G., "Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue", Proc Natl Acad Sci U S A, (20060000), vol. 103, pages 17450 - 17455 | - SUN, Y.; LODISH, H.F., "Adiponectin deficiency promotes tumor growth in mice by reducing macrophage infiltration", PloS one, (20100000), vol. 5 | - THANNICKAL, V.J.; FANBURG, B.L., "Reactive oxygen species in cell signaling", Am J Physiol Lung Cell Mol Physiol, (20000000), vol. 279, pages L1005 - L1028, XP003011373 | - USHIO-FUKAI, M.; NAKAMURA, Y., "Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy", Cancer Lett, (20080000), vol. 266, doi:doi:10.1016/j.canlet.2008.02.044, pages 37 - 52, XP022697311 DOI: http://dx.doi.org/10.1016/j.canlet.2008.02.044 | - VERINE, J.; LEHMANN-CHE, J.; SOLIMAN, H.; FEUGEAS, J.P.; VIDAL, J.S.; MONGIAT-ARTUS, P.; BELHADJ, S.; PHILIPPE, J.; LESAGE, M.; WI, "Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma", PloS one, (20100000), vol. 5, doi:doi:10.1371/journal.pone.0010421, page e10421, XP055333343 DOI: http://dx.doi.org/10.1371/journal.pone.0010421 | - WAGNER, B.A.; EVIG, C.B.; RESZKA, K.J.; BUETTNER, G.R.; BURNS, C.P., "Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells", Arch Biochem Biophys, (20050000), vol. 440, doi:doi:10.1016/j.abb.2005.06.015, pages 181 - 190, XP005027271 DOI: http://dx.doi.org/10.1016/j.abb.2005.06.015 | - WAGNER, K.D.; WAGNER, N., "Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions", Pharmacol Ther, (20100000), vol. 125, doi:doi:10.1016/j.pharmthera.2009.12.001, pages 423 - 435, XP026917084 DOI: http://dx.doi.org/10.1016/j.pharmthera.2009.12.001 | - WANG, Y.; LAM, K.S.L.; LAM, J.B.B.; LAM, M.C.; LEUNG, P.T.Y.; ZHOU, M.; XU, A., "Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice", Mol Endocrinol, (20070000), vol. 21, pages 972 - 986 | - WANG, Z.; HAN, B.; ZHANG, Z.; PAN, J.; XIA, H., "Expression of angiopoietin- like 4 and tenascin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma", Biomarkers, (20100000), vol. 15, pages 39 - 46 | - WERNER, E.; WERB, Z., "Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases", J Cell Biol, (20020000), vol. 158, pages 357 - 368 | - WESTHOFF, M.A.; FULDA, S., "Adhesion-mediated apoptosis resistance in cancer", Drug Resist Updat, (20090000), vol. 12, doi:doi:10.1016/j.drup.2009.08.001, pages 127 - 136, XP026681857 DOI: http://dx.doi.org/10.1016/j.drup.2009.08.001 | - WU, W.S., "The signaling mechanism of ROS in tumor progression", Cancer Metastasis Rev, (20060000), vol. 25, pages 695 - 705, XP019464217 | - ZHAN, M.; ZHAO, H.; HAN, Z.C., "Signalling mechanisms of anoikis", Histol Histopathol, (20040000), vol. 19, pages 973 - 983 |